WORK Medical Technology Group LTD (WOK)
| Market Cap | 4.62M -90.4% |
| Revenue (ttm) | 10.72M -0.2% |
| Net Income | -4.50M |
| EPS | -276.90 |
| Shares Out | 2.42M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 52,223 |
| Open | 1.890 |
| Previous Close | 1.900 |
| Day's Range | 1.850 - 1.950 |
| 52-Week Range | 1.780 - 930,000.000 |
| Beta | 1.75 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About WOK
WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People’s Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen ca... [Read more]
Financial Performance
In fiscal year 2025, WOK's revenue was $9.85 million, a decrease of -14.41% compared to the previous year's $11.51 million. Losses were -$1.07 million, -69.28% less than in 2024.
Financial StatementsNews
Work Medical Technology Group Ltd trading halted, news pending
19:50 EDT Work Medical (WOK) Technology Group Ltd trading halted, news pending
WORK Medical Announces 1-for-100 Reverse Stock Split Effective June 18, 2026
Auckland, New Zealand, June 16, 2026 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, today announced that...
WORK Medical Technology Group Participated in 2026 CBA-China Annual Conference
Deepening Engagement with the Global Biopharmaceutical Community Auckland, New Zealand, June 05, 2026 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company”...
WORK Medical Technology Group Establishes U.S. Subsidiary to Advance Global Expansion and Reinforce Long-Term Growth Strategy
Hangzhou, China, June 03, 2026 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company” or “we”), a supplier of medical devices in China today announced the e...
3 Penny Stocks to Watch Now, 5/14/26
Dreamland Limited ($TDIC), Quantum Cyber ($QUCY), and WORK Medical Technology Group ($WOK) are the three penny stocks to watch on May 14, according to TipRanks’ Penny Stock Screener tool. Penny…
Work Medical Technology Group Ltd trading halted, volatility trading pause
09:30 EDT Work Medical (WOK) Technology Group Ltd trading halted, volatility trading pause
Work Medical Technology Group Ltd trading resumes
09:35 EDT Work Medical (WOK) Technology Group Ltd trading resumes
3 Penny Stocks to Watch Now, 5/12/26
WORK Medical Technology Group ($WOK), Odysight.ai ($ODYS), and Jiuzi Holdings ($JZXN) are the three penny stocks to watch on May 12, according to TipRanks’ Penny Stock Screener tool. Penny stocks…
WORK Medical enters strategic cooperation agreement with Novabioplus
WORK Medical (WOK) announced that it has entered into a strategic cooperation agreement with Novabioplus. The two parties aim to jointly develop a “Data-Model-Application” trinity of next-generation i...
WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the “BioToken” Assetization Model
Hangzhou, China, May 11, 2026 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company” or “we”), a supplier of medical devices in China, through its subsidiar...
WORK Medical Deepens Web3.0 Strategic Layout: Co-authors Asset Tokenization Whitepaper
Hangzhou, China, May 01, 2026 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company” or “we”), a supplier of medical devices in China, through its subsidiar...
WORK Medical grants East China rights for Blood Cell Morphology Analyzer
WORK Medical (WOK) Technology Group, through its subsidiary, Work Medical Treatment Equipment Co., announced that its subsidiary, Hunan Saitumofei Medical Treatment Technology Co., entered into a one-...
WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026
Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical”, the “Company” or “we”), a supplier of medical devices in China, through its subsidia...
WORK Medical obtains manufacturing approval for Blood Cell Morphology Analyzer
WORK Medical (WOK) Technology announced that its subsidiary, Hunan Saitumofei received manufacturing approval from the Hunan Provincial Medical Products Administration for its Class II medical device,...
WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer
Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Wo...
WORK Medical announces 1-for-100 reverse stock split
WORK Medical (WOK) announced that it will effect a reverse stock split of its ordinary shares on a 1-for-100 basis. The company’s Class A ordinary shares will begin trading on…
WORK Medical Technology Group LTD Announces 1-for-100 Reverse Stock Split Effective December 29, 2025
Hangzhou, China, Dec. 24, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Wo...
Work Medical Technology Group Ltd trading resumes
09:35 EST Work Medical (WOK) Technology Group Ltd trading resumes
Work Medical Technology Group Ltd trading halted, volatility trading pause
09:30 EST Work Medical (WOK) Technology Group Ltd trading halted, volatility trading pause
Work Medical Technology Group Ltd trading resumes
15:32 EST Work Medical (WOK) Technology Group Ltd trading resumes
Work Medical Technology Group Ltd trading halted, volatility trading pause
15:27 EST Work Medical (WOK) Technology Group Ltd trading halted, volatility trading pause
WORK Medical’s Neologics enter $114,000 service contract
WORK Medical (WOK) Technology Group announced that its subsidiary, Neologics Bioscience, entered into a key service agreement. his move is not only a significant milestone in WORK Medical’s global exp...
WORK Medical Technology Group LTD's Subsidiary Retains a US$114,000 Service Contract from GemPharmatech Corporation
Hangzhou, China, Nov. 04, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Wo...
WORK Medical to make $1M equity investment in Neologics Bioscience
WORK Medical (WOK) Technology entered into an investment agreement with Neologics Bioscience to invest $1M in cash to acquire a 10% equity interest in Neologics. Pursuant to the Investment Agreement,…
WORK Medical Technology Group LTD Announces US$1 Million Equity Investment in Neologics Bioscience
Hangzhou, China, Oct. 21, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Wo...